Listen to the audio version of this article (generated by AI).
Today’s issue in preview:
-
How to trade the market’s biggest AI stocks from their current levels
-
The greatest bull market most people are missing
-
This one chart could change how you think about the U.S. economy
-
Learn our Top Themes to buy now
The greatest bull market most people are missing
Credit: JHVEPhoto
Will Jensen Huang return as CEO of Nvidia?
Will the upcoming Anthropic IPO be the biggest one ever?
These are the stories dominating mainstream business headlines.
While the world fixates on those stories, the Boomer healthcare megatrend continues to quietly produce winner after winner after winner. It remains the greatest bull market most people are missing.
As evidence of this uptrend, we cite the new all-time high registered today by healthcare giant Johnson & Johnson (JNJ).
Johnson & Johnson is one of the world’s largest healthcare companies, with two primary businesses: pharmaceuticals and medical technology.
Its pharmaceutical division develops treatments for cancer, autoimmune diseases, neurological disorders, and cardiovascular conditions.
J&J’s medical technology division makes surgical equipment, orthopedic implants, cardiovascular devices, and products used in minimally invasive procedures. The company is known for its enormous research budget, diversified product portfolio, strong cash flow, and long history of increasing dividends. It is a member of the exclusive “Dividend Aristocrat” club, having increased its dividend for an incredible 64 consecutive years.
Money & Megatrends readers in good standing are not surprised to see the likes of J&J registering new highs.
For more than three years, I’ve made “Boomer healthcare” one of my highest conviction long-term investment themes. We don’t know of another investment research publication that has written more bullishly, more often about this booming industry than we have.
Over the past year, we have published more than two dozen pieces on opportunities in drug development, biotechnology, senior living facilities, genomics, cardiology, diagnostics, and more.
Our bullish position has produced a parade of stock winners, with the healthcare industry dominating the stock market’s new highs list over the past year.
Healthcare stocks are generating extraordinary returns because they are benefiting from several megatrends simultaneously…
One is a demographic tsunami. More than 10,000 Americans reach retirement age every day. The U.S. population aged 80 and older is projected to roughly double, from 14.7 million in 2025 to 29.4 million by 2045.
This is the enormous Baby Boom generation entering the phase of life where health care and longevity spending skyrocket. For many boomers, a typical month involves going to see at least one doctor to have something looked at, removed, or treated.
This means many health care businesses are experiencing huge demand now – and will for at least the next decade.
Two is exponential technological progress. Thanks to major advances in genomic sequencing, AI-powered analytics, imaging technology, and preventive treatments, healthcare is becoming much better and more personalized. This is driving strong demand for all kinds of new tests, tools, and treatments.
After all, when a useful and important service you buy gets much better, you typically buy more of it.
This means many healthcare businesses are experiencing huge demand now – and will for at least the next decade.
Investing in many healthcare businesses over the next decade will be investing with a gale-force tailwind at your back. If you’re a parent and worried about your child getting a job, just point them to the booming healthcare industry.
That’s my bull case. But I care a lot more about what the market thinks of a bull case, a bear case, or any other case than what any one person thinks of it (including me).
As you can see in the two-year chart of JNJ, the market enthusiastically supports owning health care firms. JNJ has returned 49% over the past year and just reached a new all-time high. It’s further confirmation that healthcare is a good place to be.
Recommended Link:
Major Buy Alert Issued for November 30th
Keith Kaplan’s firm has invested $17 million into their own AI research and tools. He’s built a platform that 180,000 people worldwide use in the stock market. Now he says there’s a handful of stocks you need to buy before November 30th, to set yourself up for 1,000% potential returns in the near future. Here are the stocks you need to buy for the chance to profit.
How to trade the market’s biggest AI stocks from their current levels
Credit: Kenneth Cheung
Leading AI firm Anthropic is expected to go public this Thursday at an incredible valuation of $1.4 trillion+.
Given Anthropic’s growth and upside potential, it is one of the most widely followed IPOs in U.S. history. Anthropic has reported revenue for the first nine months of 2026 that is 1,206% higher than for the same period in 2025. It’s the fastest-growing large company in history.
However, as phenomenal as Anthropic’s business is… and as much public interest as it is generating, it is still not enough to restore the all-important AI infrastructure trend to good health.
Here’s why that is important for your portfolio…
Over the past three months, we’ve published a special series of research notes analyzing the AI infrastructure boom… which we’ve called “the world’s most important trend.”
The status of this critical trend has become one of the great sagas of the business and investment world… a source of intense disagreement among industry bulls and bears. It’s a trend whose outcome could have large effects on your portfolio.
Given AI’s enormous promise, large tech firms such as Alphabet (GOOG) and Microsoft (MSFT) have invested over $1 trillion in AI infrastructure. They are on pace to invest over $700 billion this year alone and more than $3 trillion after that.
Both the scale and the velocity of this investment boom are unprecedented. It is the largest collective investment effort in history.
Big Tech’s historic investment boom has made the entire “AI infrastructure” trend responsible for a large share of America’s GDP growth and stock market returns over the past two years. It has also drawn the skeptical scrutiny of many widely followed investment analysts who claim the trend is a bubble… one that will soon explode and cause tremendous damage to stock prices and the global economy.
If this hugely consequential trend isn’t the most important trend in the stock market, then it is certainly in the top three.
I believe the AI infrastructure trend has years to run. I believe the world’s smartest, most connected tech insiders who know the true state of bleeding-edge AI development and have real-time stats on AI investment ROI, such as Elon Musk, Satya Nadella (Microsoft) and Andy Jassy (Amazon), perhaps maybe… just might… know far more about AI and their businesses than outsiders know about it.
As much press as AI gets, let’s remember that less than 1% of the global population pays for top-tier AI programs. And I estimate less than 10% of large companies believe AI has made a meaningful impact on their businesses.
This revolutionary technology hasn’t yet proliferated, achieved mass adoption, or had mass impact. However, the Agent Supernova is coming.
I like to know the bull and the bear case for any trend. But regular readers know I care a lot more about what the market thinks of any stock, trend, or theme than what any one person thinks of it, including me. You can be bullish or bearish on a trend all you like, but if that trend is moving strongly against you, then your idea isn’t worth a hell of a lot in my book.
One of the best ways to gauge what the market thinks of AI infrastructure is analyzing the VanEck Semiconductor ETF (SMH).
This fund is full of key semiconductor firms whose fortunes rise and fall with AI infrastructure spending trends. Major holdings include Nvidia (NVDA), Taiwan Semiconductor (TSM), AMD (AMD), Texas Instruments (TXN), ASML Holding (ASML) and Micron (MU).
As you can see in the two-year chart below, SMH enjoyed a gigantic run from June 2025 to June 2026. The fund gained 176%. After reaching a high in June 2026, however, the fund corrected and moved in a volatile, sideways pattern.
Enormous selling pressure over the past month has sent SMH out of its consolidation pattern and into meaningful new short-term lows. Virtually every other facet of the AI infrastructure trade looks the same.
We cannot say if these new lows portend a “blow up” of the AI trade. But we can say they have dealt serious damage to the AI infrastructure stock trend. Despite all the reports of tremendous growth in AI businesses such as Anthropic, OpenAI, and SpaceX, the AI infrastructure trend is not getting boosted back near new highs.
Here’s how I’m trading this situation: Although I believe this trend eventually makes it way higher, I’m not putting one dollar into it until it can prove to me it has healthy buying support.
All trends – including this one – are guilty until proven innocent in my book. They can prove their innocence by attracting huge money flows and moving with upside purpose. SMH isn’t doing any of that right now.
We will continue to provide frequent analysis and guidance on the “world’s most important trend” as it unfolds.
This one chart could change how you think about the U.S economy
Credit: jetcityimage
The U.S. economy has all kinds of risks and imbalances. But it also has many enormous positives working in its favor. And right now, those enormous positives are bulldozing the negatives aside and marching economic growth higher.
Case in point: Darden Restaurants (DRI) is doing brisk business, and its stock just reached a new all-time high. It’s a bull market in Full-Service Restaurants (FSRs).
Here’s why that is great for your retirement account…
You may not know the name Darden, but you know what it owns.
Darden is the large holding company that owns and operates Olive Garden, LongHorn Steakhouse, Ruth’s Chris, The Capital Grille, Yard House, and Seasons 52. It is America’s largest Full-Service Restaurant (FSR) operator.
Over the past six months, we have regularly checked in on the bull market in FSR stocks such as The Cheesecake Factory (CAKE), Brinker International (EAT, owner of Chili’s), Texas Roadhouse (TXRH), and Darden.
These uptrends are important because they give us an informed, real-time analysis of American consumer health.
A full-service restaurant is one where you’re seated by a host, talk to a server, have your food brought to you, and hopefully leave a nice tip. This experience is different from a fast-food restaurant such as McDonald’s or Chick-fil-A.
It is also more expensive.
The typical family of four going to a full-service restaurant knows it will be spending considerably more there than at a fast-food joint.
Because FSR bills are on the higher end of the dining cost spectrum, the earnings and stock prices of these chains are excellent “real world” indicators that signal a lot about the financial health of the American consumer.
After all, dropping $150 on dinner is not something most people do when they are broke. It is something people are more likely to do when they are gainfully employed, making money, and optimistic about tomorrow.
Driven by strong business performance, American FSR stocks are in a clear uptrend. And Darden – its undisputed leader – just reached a new all-time high.
Over the past two months, I’ve written over a dozen research notes analyzing the soaring share prices of highly economically sensitive industry groups, including railroad stocks, regional banks, manufacturing stocks, steelmakers, Best Buy (BBY),Williams-Sonoma (WSM), and hotel chains.
At the end of each note, I pointed to their soaring stock prices and told readers that the U.S. economy is doing much better than most people think.
These economically sensitive firms are important “real world” indicators. They almost always do a better job of telling us what is happening in the economy than any media outlet or economist. And their uptrends are moving in a bullish upward direction for the U.S.A.
Market Notes
-
The GLP-1 drug boom continues. GLP-1 leader Eli Lilly (LLY) reached a new all-time high today.
-
The bull market in Healthcare Diagnostics continues. Diagnostics giant Quest Diagnostics (DGX) reached a new all-time high today.
-
Solar panel giant First Solar (FSLR) reached a new one-year low today.
-
Crypto exchange and infrastructure giant Coinbase (COIN) reached a new 2-year low today.
-
Chinese technology giant Alibaba (BABA) reached a new one-year low today.
Top Themes to Buy Now
💊 An important “tell” from the market.
🛢️ How the AI boom can pay you steady streams of income
🤖
This stock is the best way to invest in AI and robotics at the same time
Regards,

Brian Hunt
Editor, Money & Megatrends
An urgent message from our colleagues:
Ron Paul: “Sorry Socialists, more handouts won’t fix this”
The Democratic Socialists more than tripled their votes in Congress and even took the D.C. mayor’s office. But 12-term former Congressman Ron Paul says the most dangerous economic force in America took over Washington long before the election – and could reach a breaking point in the coming weeks. In this free new video, he reveals the #1 step Americans should take to protect themselves now.
Click here now.









